BIRC5 and cancer: Townley and Wheatley (2020) showed that survivin localizes in the mitochondria of malignant cells and its mitochondrial residence represents a gain of function over its physiological roles, driving cancer development and progression by reducing oxidative phosphorylation with greater dependency on glycolysis, changes that evoke the ‘Warburg effect’ [25].